drugset / Trial / NCT04227288

A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis

NCT04227288

NaSingle-groupOpen-labelTreatment

Summary

The aim of the study is to evaluate the efficacy and safety of Enstilar Foam (calcipotriene and betamethasone dipropionate) for the treatment of nail psoriasis.

Timeline

Start
2021-11-01
Primary completion
2023-10-31
Completion
2023-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule Topical
Subject betamethasone dipropionate Small molecule Topical

Indications